We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-0.09%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$235M
AUM Growth
+$87.8M
Cap. Flow
+$81.1M
Cap. Flow %
34.53%
Top 10 Hldgs %
9.76%
Holding
779
New
236
Increased
178
Reduced
104
Closed
257

Top Sells

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$1.39M
2
ETN icon
Eaton
ETN
+$1.38M
3
CB
CHUBB CORPORATION
CB
+$1.35M
4
XEC
CIMAREX ENERGY CO
XEC
+$1.32M
5
DVA icon
DaVita
DVA
+$1.26M

Sector Composition

Rank Sector Weight
1 Technology 15.9%
2 Consumer Discretionary 14.51%
3 Industrials 13.73%
4 Financials 13.03%
5 Healthcare 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFG icon
651
Principal Financial Group
PFG
$24.3B
-4,046
Closed -$182K
PII icon
652
Polaris
PII
$3.83B
-1,000
Closed -$86K
PPC icon
653
Pilgrim's Pride
PPC
$7.13B
-3,101
Closed -$69K
PPG icon
654
PPG Industries
PPG
$24.9B
-6,700
Closed -$662K
PRAA icon
655
PRA Group
PRAA
$672M
-100
Closed -$3K
PRGO icon
656
Perrigo
PRGO
$1.44B
-83
Closed -$12K
PRTA icon
657
Prothena Corp
PRTA
$448M
-1,200
Closed -$82K
PVH icon
658
PVH
PVH
$4.07B
-6,200
Closed -$457K
QCOM icon
659
Qualcomm
QCOM
$164B
-5,395
Closed -$270K
QRVO icon
660
Qorvo
QRVO
$7.9B
-500
Closed -$25K
R icon
661
Ryder
R
$9.9B
-200
Closed -$11K
RARE icon
662
Ultragenyx Pharmaceutical
RARE
$2.46B
-300
Closed -$34K
RDN icon
663
Radian Group
RDN
$5.28B
-29,409
Closed -$394K
ROK icon
664
Rockwell Automation
ROK
$51.1B
-4,650
Closed -$477K
ROST icon
665
Ross Stores
ROST
$80.8B
-924
Closed -$50K
RTX icon
666
RTX Corp
RTX
$290B
-5,630
Closed -$340K
SBAC icon
667
SBA Communications
SBAC
$19.8B
-1,343
Closed -$141K
SBGI icon
668
Sinclair Inc
SBGI
$1.02B
-2,700
Closed -$88K
SBH icon
669
Sally Beauty Holdings
SBH
$1.47B
-2,000
Closed -$56K
SCCO icon
670
Southern Copper
SCCO
$138B
-21,284
Closed -$515K
SEIC icon
671
SEI Investments
SEIC
$12.3B
-700
Closed -$37K
SLB icon
672
SLB Ltd
SLB
$72.7B
-1,789
Closed -$125K
SLM icon
673
SLM Corp
SLM
$4.83B
-56,800
Closed -$370K
SRE icon
674
Sempra
SRE
$58.1B
-19,600
Closed -$921K
SRPT icon
675
Sarepta Therapeutics
SRPT
$1.64B
-3,700
Closed -$143K

Similar funds

Seven Eight Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Seven Eight Capital held 779 positions worth $235M, up 60% from $147M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Seven Eight Capital deployed $81.1M of net new capital in Q1 2016, opening 236 new positions and adding to 178 existing holdings. Its largest new stake was Allergan plc: 8,800 shares worth $2.36M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $884K trimmed.

  • Seven Eight Capital's largest Q1 2016 buy was Allergan plc: 8,800 shares worth $2.36M.
  • Seven Eight Capital added most to Wells Fargo in Q1 2016, an estimated $2.19M increase.
  • Seven Eight Capital's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $884K.
  • Seven Eight Capital fully exited Halliburton in Q1 2016, selling an estimated $1.39M.
  • Seven Eight Capital's ten largest holdings make up 9.8% of its $235M portfolio in Q1 2016.
  • Seven Eight Capital opened 236 new positions and closed 257 in Q1 2016.
  • Seven Eight Capital's portfolio value rose 60% quarter-over-quarter to $235M.

Based on Seven Eight Capital's 13F filing for Q1 2016, filed 16 May 2016.